Dental membrane and bone graft substitute market

Dental Membrane And Bone Graft Substitute Market, by Product Type (Dental Membranes, (Resorbable Membranes, Non-Resorbable Membranes), Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft, Bovine Xenograft, Porcine Xenograft, Synthetic Bone Graft Substitutes)), by Material Type (Hydrogel, Collagen, Human Cells Source, Other Species, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), Polytetrafluoroethylene), by End User (Hospitals, Dental Clinics, Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Nov 2022
CMI1143
199 Pages
Excel & Pdf
Medical Devices

Summary

Bone grafting can be used in dental procedures, such as, dental implant placement, tooth extraction, facial trauma treatment and reconstructive surgery of the mouth, face and jaws. It provide good quantity and quality of bone at the desired site for proper form and function .Dental membranes and bone graft substitutes are used for dental bone regeneration procedures in patients affected by oral health disorders such as periodontal diseases and oral cancer. Dental membranes are used alongside dental bone grafts to allow cell proliferation during regeneration process. The increasing demand for dental implants for bone regeneration process is expected to offer lucrative growth opportunities for market players in the global dental membranes and bone graft substitutes market.

The global dental membranes and bone graft substitutes market is estimated to be valued at US$ 1,045.3 million in 2022 and is expected to exhibit a CAGR of 9.4% during the forecast period (2022-2030).

Figure 1. Global Dental Membranes and Bone Graft Substitutes Market Share (%), by Product Type, 2022

Global Dental Membranes and Bone Graft Substitutes Market - Drivers

Increasing adoption of inorganic strategies such as product approval by key market players is expected to boost growth of the dental membranes and bone graft substitutes market. For instance, in May 2022, BONESUPPORT AB, an orthobiologics company, announced that they had received market authorization from the U.S. Food and Drug Administration for Cerament G, the first and only bone graft substitute that provide a gap filler during the surgical procedures and manage bone defect.

Dental Membranes and Bone Graft Substitutes Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 1,045.3 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	9.4%	2030 Value Projection:	US$ 2,141.9 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Dental Membranes (Resorbable Membranes, Non-Resorbable Membranes), Bone Graft Substitutes (Demineralized Bone Matrix (DBM), Allograft, Xenograft, Bovine Xenograft, Porcine Xenograft, Synthetic Bone Graft Substitutes) By Material Type: Hydrogel, Collagen, Human Cells Source, Other Species, Hydroxyapatite (HA), Tricalcium Phosphate (TCP), Polytetrafluoroethylene By End User: Hospitals, Dental Clinics, Ambulatory Surgical Centers
Companies covered:	Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp.
Growth Drivers:	Increasing adoption of inorganic strategies such as product approval by key market players
Restraints & Challenges:	Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration

Figure 2. Global Dental Membranes and Bone Graft Substitutes Market Value (US$ Million), by Region, 2022

Global Dental Membranes and Bone Graft Substitutes Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a negative impact on the global dental membranes and bone graft substitutes market. For instance, in 2022, according to the data published by American Board of Oral and Maxillofacial Surgery, dental implants and bone regenerative procedures have been decreased due to COVID-19. As blood vessels or micro vascular are affected by Covid-19 which results in bone loss and decreased bone formation.

Global Dental Membranes and Bone Graft Substitutes Market: Key Developments

Adoption of inorganic strategies such as acquisition by key market players is expected to drive the global dental membranes and bone graft substitutes market over the forecast period. For instance, in January 2021, Dentsply Sirona Inc., a manufacturer of dental products, announced that they had acquired Datum Dental, Ltd., a biotechnology company. This acquisition will developed dental regenerative procedures and empower dental professionals to provide patients with better dental care.

Global Dental Membranes and Bone Graft Substitutes Market: Restraint

Increasing number of product recalls by government agencies such as the U.S. Food and Drug Administration is the major factor that is expected to hinder the growth of the global dental membranes and bone graft substitutes market. For instance, in April 2021, the U.S. Food and Drug Administration recalled class 3 device iFACTOR peptide enhanced bone graft, which was manufactured by Cerapedics, Inc., an orthobiologics company, the product was recalled due to the incorrect part number and volume amount in patient chart labels.

Global Dental Membranes and Bone Graft Substitutes Market - Key Players

Major players operating in the global dental membranes and bone graft substitutes market include Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp.

Table of Content

Table of Contents

*Browse 35 market data tables and 42 figures on "Global Dental Membranes and Bone Graft Substitutes Market” - forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global dental membranes and bone graft substitutes market during the forecast period (2022-2030)?

The global dental membranes and bone graft substitutes market size is estimated to be valued at US$ 1,045.3 million in 2022 and is expected to exhibit a CAGR of 9.4% between 2022 and 2030.

What are the major factors driving the market growth?

Increasing adoption of inorganic strategies such as product approval by key market players is expected to drive the market.

Which is the leading the product type segment in the market?

Dental membranes are the leading product type segment in the market.

What are the key factors hampering growth of the market?

The key factors hampering growth of the market include increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration.

Which are the major players operating in the market?

Major players operating in the market include Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp.